S&P 500   3,208.52 (-0.56%)
DOW   26,705.26 (-0.61%)
QQQ   258.80 (-0.80%)
AAPL   385.90 (-1.28%)
MSFT   204.07 (-1.91%)
FB   239.86 (-0.17%)
GOOGL   1,509.33 (-0.50%)
AMZN   3,017.58 (+0.29%)
NVDA   405.77 (-0.81%)
CGC   18.20 (+0.28%)
BABA   244.29 (-1.97%)
MU   49.99 (-1.03%)
GE   7.11 (-0.42%)
TSLA   1,522.74 (-1.51%)
AMD   54.57 (-1.39%)
T   30.30 (+0.97%)
ACB   12.18 (-5.36%)
F   6.84 (+1.48%)
GILD   76.09 (-0.73%)
DIS   119.42 (-1.22%)
NFLX   530.91 (+1.46%)
BAC   23.91 (-2.80%)
BA   181.18 (-3.60%)
S&P 500   3,208.52 (-0.56%)
DOW   26,705.26 (-0.61%)
QQQ   258.80 (-0.80%)
AAPL   385.90 (-1.28%)
MSFT   204.07 (-1.91%)
FB   239.86 (-0.17%)
GOOGL   1,509.33 (-0.50%)
AMZN   3,017.58 (+0.29%)
NVDA   405.77 (-0.81%)
CGC   18.20 (+0.28%)
BABA   244.29 (-1.97%)
MU   49.99 (-1.03%)
GE   7.11 (-0.42%)
TSLA   1,522.74 (-1.51%)
AMD   54.57 (-1.39%)
T   30.30 (+0.97%)
ACB   12.18 (-5.36%)
F   6.84 (+1.48%)
GILD   76.09 (-0.73%)
DIS   119.42 (-1.22%)
NFLX   530.91 (+1.46%)
BAC   23.91 (-2.80%)
BA   181.18 (-3.60%)
S&P 500   3,208.52 (-0.56%)
DOW   26,705.26 (-0.61%)
QQQ   258.80 (-0.80%)
AAPL   385.90 (-1.28%)
MSFT   204.07 (-1.91%)
FB   239.86 (-0.17%)
GOOGL   1,509.33 (-0.50%)
AMZN   3,017.58 (+0.29%)
NVDA   405.77 (-0.81%)
CGC   18.20 (+0.28%)
BABA   244.29 (-1.97%)
MU   49.99 (-1.03%)
GE   7.11 (-0.42%)
TSLA   1,522.74 (-1.51%)
AMD   54.57 (-1.39%)
T   30.30 (+0.97%)
ACB   12.18 (-5.36%)
F   6.84 (+1.48%)
GILD   76.09 (-0.73%)
DIS   119.42 (-1.22%)
NFLX   530.91 (+1.46%)
BAC   23.91 (-2.80%)
BA   181.18 (-3.60%)
S&P 500   3,208.52 (-0.56%)
DOW   26,705.26 (-0.61%)
QQQ   258.80 (-0.80%)
AAPL   385.90 (-1.28%)
MSFT   204.07 (-1.91%)
FB   239.86 (-0.17%)
GOOGL   1,509.33 (-0.50%)
AMZN   3,017.58 (+0.29%)
NVDA   405.77 (-0.81%)
CGC   18.20 (+0.28%)
BABA   244.29 (-1.97%)
MU   49.99 (-1.03%)
GE   7.11 (-0.42%)
TSLA   1,522.74 (-1.51%)
AMD   54.57 (-1.39%)
T   30.30 (+0.97%)
ACB   12.18 (-5.36%)
F   6.84 (+1.48%)
GILD   76.09 (-0.73%)
DIS   119.42 (-1.22%)
NFLX   530.91 (+1.46%)
BAC   23.91 (-2.80%)
BA   181.18 (-3.60%)
Log in

NASDAQ:LQDALiquidia Technologies News Headlines

$6.68
+0.08 (+1.21 %)
(As of 07/16/2020 01:50 PM ET)
Add
Compare
Today's Range
$6.10
Now: $6.68
$6.68
50-Day Range
$6.70
MA: $8.71
$11.44
52-Week Range
$2.65
Now: $6.68
$12.10
Volume11,756 shs
Average Volume584,836 shs
Market Capitalization$189.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.82

Headlines

Liquidia Technologies (NASDAQ LQDA) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect Liquidia Technologies Inc (NASDAQ:LQDA) Will Post Earnings of -$0.39 Per ShareZacks: Brokerages Expect Liquidia Technologies Inc (NASDAQ:LQDA) Will Post Earnings of -$0.39 Per Share
www.americanbankingnews.com - July 11 at 1:46 PM
Q2 2020 EPS Estimates for Liquidia Technologies Inc Boosted by Analyst (NASDAQ:LQDA)Q2 2020 EPS Estimates for Liquidia Technologies Inc Boosted by Analyst (NASDAQ:LQDA)
www.americanbankingnews.com - July 9 at 6:16 AM
Needham & Company LLC Reaffirms Buy Rating for Liquidia Technologies (NASDAQ:LQDA)Needham & Company LLC Reaffirms Buy Rating for Liquidia Technologies (NASDAQ:LQDA)
www.americanbankingnews.com - July 7 at 5:06 PM
Pulmonary Arterial Hypertension Could Help Liquidia Technologies Stock Rise Over 300%Pulmonary Arterial Hypertension Could Help Liquidia Technologies Stock Rise Over 300%
www.msn.com - July 7 at 12:35 PM
Liquidia Technologies (LQDA) Buy Rating Reiterated at WedbushLiquidia Technologies' (LQDA) Buy Rating Reiterated at Wedbush
www.americanbankingnews.com - July 7 at 9:00 AM
Liquidia Technologies Inc (NASDAQ:LQDA) Sees Large Increase in Short InterestLiquidia Technologies Inc (NASDAQ:LQDA) Sees Large Increase in Short Interest
www.americanbankingnews.com - July 5 at 10:37 PM
Eshelman Ventures, Llc Acquires 1,875,000 Shares of Liquidia Technologies Inc (NASDAQ:LQDA) StockEshelman Ventures, Llc Acquires 1,875,000 Shares of Liquidia Technologies Inc (NASDAQ:LQDA) Stock
www.americanbankingnews.com - July 3 at 4:17 AM
Liquidia Announces Closing of Public Offering of Common StockLiquidia Announces Closing of Public Offering of Common Stock
finance.yahoo.com - July 2 at 7:27 PM
Liquidia moves to acquire Durham firm, raise $75 millionLiquidia moves to acquire Durham firm, raise $75 million
www.bizjournals.com - June 30 at 8:37 AM
Liquidia Announces Pricing of Public Offering of Common StockLiquidia Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - June 30 at 3:36 AM
Liquidia to Host Conference Call to Provide Update on Recent AnnouncementsLiquidia to Host Conference Call to Provide Update on Recent Announcements
finance.yahoo.com - June 30 at 3:36 AM
Liquidia to acquire RareGen in all-stock dealLiquidia to acquire RareGen in all-stock deal
seekingalpha.com - June 29 at 5:10 PM
Liquidia to Acquire RareGen, LLC, and Expand Presence in PAHLiquidia to Acquire RareGen, LLC, and Expand Presence in PAH
finance.yahoo.com - June 29 at 5:10 PM
Liquidia Announces Proposed Offering of Common StockLiquidia Announces Proposed Offering of Common Stock
finance.yahoo.com - June 29 at 5:10 PM
Liquidia Technologies Inc (NASDAQ:LQDA) Given Average Recommendation of "Buy" by BrokeragesLiquidia Technologies Inc (NASDAQ:LQDA) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 24 at 3:43 AM
Liquidia Technologies Inc (NASDAQ:LQDA) Sees Significant Growth in Short InterestLiquidia Technologies Inc (NASDAQ:LQDA) Sees Significant Growth in Short Interest
www.americanbankingnews.com - June 22 at 10:43 PM
Is Liquidia Technologies (NASDAQ:LQDA) Using Debt In A Risky Way?Is Liquidia Technologies (NASDAQ:LQDA) Using Debt In A Risky Way?
finance.yahoo.com - June 16 at 1:24 PM
Do Hedge Funds Love Liquidia Technologies, Inc. (LQDA)?Do Hedge Funds Love Liquidia Technologies, Inc. (LQDA)?
finance.yahoo.com - June 12 at 11:59 PM
North Carolina biotech responds to United Therapeutics lawsuitNorth Carolina biotech responds to United Therapeutics lawsuit
www.bizjournals.com - June 8 at 5:57 PM
TBJ Plus: United Therapeutics sues Triangle firm; NC billionaires get richer; Raleigh recognized for #BLMTBJ Plus: United Therapeutics sues Triangle firm; NC billionaires get richer; Raleigh recognized for #BLM
www.bizjournals.com - June 8 at 12:56 PM
United Therapeutics sues Liquidia over infringement of Tyvaso patentsUnited Therapeutics sues Liquidia over infringement of Tyvaso patents
seekingalpha.com - June 5 at 9:42 AM
Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?
finance.yahoo.com - May 22 at 12:26 PM
New medical chief at Liquidia TechnologiesNew medical chief at Liquidia Technologies
seekingalpha.com - May 18 at 9:44 AM
Liquidia Technologies (LQDA) CEO Neal Fowler on Q1 2020 Results - Earnings Call TranscriptLiquidia Technologies' (LQDA) CEO Neal Fowler on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 3:20 AM
Liquidia Technologies EPS beats by $0.02Liquidia Technologies EPS beats by $0.02
seekingalpha.com - May 11 at 5:19 PM
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate UpdateLiquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 11 at 5:19 PM
Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial HypertensionLiquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension
finance.yahoo.com - May 3 at 2:29 AM
Liquidia to Present at the 19th Annual Needham Healthcare ConferenceLiquidia to Present at the 19th Annual Needham Healthcare Conference
finance.yahoo.com - April 9 at 9:22 AM
FDA accepts Liquidias marketing application for LIQ861FDA accepts Liquidia's marketing application for LIQ861
seekingalpha.com - April 8 at 12:19 PM
Liquidia Announces FDA Acceptance of New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial HypertensionLiquidia Announces FDA Acceptance of New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
finance.yahoo.com - April 8 at 12:19 PM
Liquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q4 2019 Results - Earnings Call TranscriptLiquidia Technologies, Inc. (LQDA) CEO Neal Fowler on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 11 at 1:38 PM
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Misses Revenue EstimatesLiquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 11 at 1:38 PM
Liquidia Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateLiquidia Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 11 at 8:37 AM
Will Liquidia Technologies, Inc. (LQDA) Report Negative Earnings Next Week? What You Should KnowWill Liquidia Technologies, Inc. (LQDA) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - March 4 at 2:59 PM
Liquidia to Report 2019 Financial Results and Provide Corporate Update on March 11, 2020Liquidia to Report 2019 Financial Results and Provide Corporate Update on March 11, 2020
finance.yahoo.com - February 26 at 5:36 PM
Liquidia to Present at Cowen 40th Annual Health Care ConferenceLiquidia to Present at Cowen 40th Annual Health Care Conference
finance.yahoo.com - February 26 at 5:36 PM
Looking Into Liquidia TechnologiesLooking Into Liquidia Technologies
seekingalpha.com - February 10 at 11:30 PM
Liquidia seeks pivotal FDA approval for lead drugLiquidia seeks pivotal FDA approval for lead drug
finance.yahoo.com - January 27 at 7:30 PM
Liquidia files U.S. application for inhaled formulation of treprostinilLiquidia files U.S. application for inhaled formulation of treprostinil
seekingalpha.com - January 27 at 2:29 PM
Liquidia Submits New Drug Application for LIQ861 (treprostinil) inhalation powder to U.S. Food and Drug Administration for the Treatment of Pulmonary Arterial Hypertension (PAH)Liquidia Submits New Drug Application for LIQ861 (treprostinil) inhalation powder to U.S. Food and Drug Administration for the Treatment of Pulmonary Arterial Hypertension (PAH)
finance.yahoo.com - January 27 at 9:28 AM
Liquidia Announces Poster Presentation at the 14th Annual World Congress of the Pulmonary Vascular Research Institute (PVRI)Liquidia Announces Poster Presentation at the 14th Annual World Congress of the Pulmonary Vascular Research Institute (PVRI)
finance.yahoo.com - January 24 at 4:57 PM
Will Liquidia Continue to Surge Higher?Will Liquidia Continue to Surge Higher?
finance.yahoo.com - January 15 at 2:40 PM
34 Stocks Moving In Thursdays Mid-Day Session34 Stocks Moving In Thursday's Mid-Day Session
www.msn.com - December 26 at 10:20 PM
Liquidia nets $22.4 million as it moves forward with lead drugLiquidia nets $22.4 million as it moves forward with lead drug
finance.yahoo.com - December 26 at 5:20 PM
Liquidia surges as Wedbush sees placement extending runwayLiquidia surges as Wedbush sees placement extending runway
seekingalpha.com - December 26 at 12:19 PM
Liquidia Technologies stock soars after Wedbush says private placement gives company runway through Q4 2020Liquidia Technologies stock soars after Wedbush says private placement gives company runway through Q4 2020
finance.yahoo.com - December 26 at 12:19 PM
Liquidia launches $22.4M private placementLiquidia launches $22.4M private placement
seekingalpha.com - December 24 at 8:58 AM
Liquidia Technologies Announces $22.4 Million Private PlacementLiquidia Technologies Announces $22.4 Million Private Placement
finance.yahoo.com - December 24 at 8:58 AM
Is Liquidia Technologies, Inc. (LQDA) A Good Stock To Buy?Is Liquidia Technologies, Inc. (LQDA) A Good Stock To Buy?
finance.yahoo.com - December 20 at 10:34 PM
BRIEF-Liquidia Technologies Reports Q3 Net Loss Of $0.72 Per ShareBRIEF-Liquidia Technologies Reports Q3 Net Loss Of $0.72 Per Share
www.msn.com - November 13 at 10:57 PM
This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.